Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

FATE holding history

Fate Therapeutics Inc in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FATE overviewAll 13F holders of FATEFull Q2 2026 holdings

Shares (Q2 2026)
12,872,946
Value
$34.8M
% of portfolio
2.3%
Quarters held
22
Since Q1 2021
Holdings of FATE by Redmile Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,872,946$34.8M2.3%00.0%UnchangedHolders
Q1 202612,872,946$15.4M1.0%00.0%UnchangedHolders
Q4 202512,872,946$12.6M0.9%00.0%UnchangedHolders
Q3 202512,872,946$16.2M1.6%00.0%UnchangedHolders
Q2 202512,872,946$14.4M1.5%00.0%UnchangedHolders
Q1 202512,872,946$10.2M1.0%00.0%UnchangedHolders
Q4 202412,872,946$21.2M1.5%−296,111−2.2%ReducedHolders
Q3 202413,169,057$46.1M2.7%00.0%UnchangedHolders
Q2 202413,169,057$43.2M2.6%00.0%UnchangedHolders
Q1 202413,169,057$96.7M3.5%00.0%UnchangedHolders
Q4 202313,169,057$49.3M1.8%+44,630+0.3%AddedHolders
Q3 202313,124,427$27.8M1.3%00.0%UnchangedHolders
Q2 202313,124,427$62.5M2.4%+167,205+1.3%AddedHolders
Q1 202312,957,222$73.9M3.2%00.0%UnchangedHolders
Q4 202212,957,222$130.7M5.3%00.0%UnchangedHolders
Q3 202212,957,222$290.4M11.3%00.0%UnchangedHolders
Q2 202212,957,222$321.1M12.3%00.0%UnchangedHolders
Q1 202212,957,222$502.4M15.7%00.0%UnchangedHolders
Q4 202112,957,222$758.1M17.2%00.0%UnchangedHolders
Q3 202112,957,222$768.0M13.4%00.0%UnchangedHolders
Q2 202112,957,222$1.12B16.6%00.0%UnchangedHolders
Q1 202112,957,222$1.07B15.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.